Ref (type)	Population	Outcome, Interventions	Results and statistical analysis	Effect size	Favours
Adverse effects
RCT	345 people with H pylori infection and current or previously active peptic ulcers	Adverse effects with rabeprazole-based triple regimen for 7 days with omeprazole-based triple regimen for 7 days
RCT	90 people with H pylori infection and non-ulcer dyspepsia	Rate of adverse effects with pantoprazole-based triple regimen for 14 days (including clarithromycin plus amoxicillin) with lansoprazole-based triple regimen for 14 days (including clarithromycin plus amoxicillin)	Reported as not significant P value not reported		Not significant